Description: In the past months, as COVID-19 has forced the reduced activity in the U.S. economy there has been some very substantial, but varied effects on the U.S. healthcare system. There is a lot of potential for confusion amongst providers and patients with regards to decisions related to which services ought to be rendered and which ought to be deferred. Two specific agencies – the Centers for Medicare and Medicaid Services (CMS), and the American College of Surgeons (ACS) have put together some guidance to add more clarity towards what types of services should be provided and what types ought to be deferred. In addition, this paper includes a discussion on what types of services are most likely to be deferred, and which ones will accrue pent-up demand to be released when many of the deferred services become available again.

Description: In this session 153 PD of the New York Annual Meeting panelists look at the actuarial background, financial implications, underwriting, and solvency issues posed by various newsworthy items. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: This editorial gives an overview of articles in this edition of The Actuary including actuarial exams and health care management issues.

Description: The SOA released a report titled Massachusetts Health Insurance Reform, which looks at the impact on insurance markets, pricing and profitability.

Description: This Society of Actuaries, working with LIMRA, Oliver Wyman and the American Council of Life Insurers, is releasing a series of pulse surveys aimed at obtaining a quick read on how the COVID-19 pandemic is impacting insurance companies and reinsurers.

Description: This session will recap the history of the involvement of the actuarial profession in the debates on health care reform. From the Record of the Society of Actuaries, Vol. 21, No. 4b.

Description: SOA interview with David Axene

Description: This Society of Actuaries Research Brief has been constructed to highlight some of the key features of the pandemic and contemplate the risks for the actuarial profession to consider in their work.

Description: Cost Effectiveness of Tumor Genomic Analysis and Immunotherapy

Description: This discussion at the 1989 Valuation Actuary Symposium focuses on methods and considerations that are currently being used in analyzing various risks of concern to the health valuation actuary. The session looks at concepts and types of risks, considerations and influences affecting the actuary, formulas and methods for evaluating risk, and the present status of the health insurance valuation actuary concept.